Louis E. Schroder

Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo.

Harry R. Maxon, Louis E. Schroder, Vicki Hertzberg et al. · PubMed · 1991 · 166 citations

Painful Osseous Metastases, Surgical Oncology, Radioactive Placebo +20

Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer.

Harry R. Maxon, Louis E. Schroder, Stephen R. Thomas et al. · Radiology · 1990 · 146 citations

Painful Osseous Metastases, Surgical Oncology, Engineering +18

Rhenium-188(Sn)HEDP for treatment of osseous metastases.

Harry R. Maxon, Louis E. Schroder, Lee C. Washburn et al. · PubMed · 1998 · 85 citations

Safety and Efficacy of Repeated Sequential Administrations of Re-186(Sn)HEDP as Palliative Therapy for Painful Skeletal Metastases

Emanuela Englaro, Louis E. Schroder, Stephen Thomas et al. · Clinical Nuclear Medicine · 1992 · 29 citations

Painful Skeletal Metastases, Surgical Oncology, Urology +14

Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide - a Southwest Oncology Group clinical and pharmacokinetic study

Steven M. Grunberg, John Crowley, Kenneth R. Hande et al. · Cancer Chemotherapy and Pharmacology · 1999 · 17 citations

Medicine, Southwest Oncology Group, Pharmacology +9